Michael R. Orford - Publications

Classic ketogenic diet versus further antiseizure medicine in infants with drug-resistant epilepsy (KIWE): a UK, multicentre, open-label, randomised clinical trial.

Journal: The Lancet. Neurology

Published: June 26, 2023

Randomization to a Liberal Versus Conservative Oxygenation Target: Redox Responses in Critically Ill Children.

Journal: Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies

Published: February 02, 2023

Role of CD14+ monocyte-derived oxidised mitochondrial DNA in the inflammatory interferon type 1 signature in juvenile dermatomyositis.

Journal: Annals of the rheumatic diseases

Published: October 11, 2022

Mitochondrial dysfunction is a key pathological driver of early stage Parkinson's.

Journal: Acta neuropathologica communications

Published: June 10, 2022

Remote Ischaemic Pre-Conditioning Reduces Intestinal Ischaemia Reperfusion Injury in a Newborn Rat.

Journal: Journal of pediatric surgery

Published: May 25, 2022

Investigating Genetic Determinants of Plasma Inositol Status in Adult Humans.

Journal: The Journal of nutrition

Published: May 24, 2022

Human Immunocompetent Model of Neuroendocrine Liver Metastases Recapitulates Patient-Specific Tumour Microenvironment.

Journal: Frontiers in endocrinology

Published: March 31, 2022

Protective effects of medium chain triglyceride diet in a mouse model of Dravet syndrome.

Journal: Epilepsia

Published: March 25, 2021

K.Vita: a feasibility study of a blend of medium chain triglycerides to manage drug-resistant epilepsy.

Journal: Brain communications

Published: March 03, 2021

Beclin-1-mediated activation of autophagy improves proximal and distal urea cycle disorders.

Journal: EMBO molecular medicine

Published: July 22, 2020

The Microfluidic Environment Reveals a Hidden Role of Self-Organizing Extracellular Matrix in Hepatic Commitment and Organoid Formation of hiPSCs.

Journal: Cell reports

Published: February 20, 2020

Liposomal delivery of hydrophobic RAMBAs provides good bioavailability and significant enhancement of retinoic acid signalling in neuroblastoma tumour cells.

Journal: Journal of drug targeting

Published: January 07, 2020